These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 39273284)

  • 21. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.
    Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
    Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary paternal genetic landscape of Polish and German populations: from early medieval Slavic expansion to post-World War II resettlements.
    Rębała K; Martínez-Cruz B; Tönjes A; Kovacs P; Stumvoll M; Lindner I; Büttner A; Wichmann HE; Siváková D; Soták M; Quintana-Murci L; Szczerkowska Z; Comas D;
    Eur J Hum Genet; 2013 Apr; 21(4):415-22. PubMed ID: 22968131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.
    Krivokuca A; Dragos VS; Stamatovic L; Blatnik A; Boljevic I; Stegel V; Rakobradovic J; Skerl P; Jovandic S; Krajc M; Magic MB; Novakovic S
    Fam Cancer; 2018 Apr; 17(2):179-185. PubMed ID: 28685474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial DNA perspective of Serbian genetic diversity.
    Davidovic S; Malyarchuk B; Aleksic JM; Derenko M; Topalovic V; Litvinov A; Stevanovic M; Kovacevic-Grujicic N
    Am J Phys Anthropol; 2015 Mar; 156(3):449-65. PubMed ID: 25418795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of 845G>A HFE mutation in Slavic populations: an east-west linear gradient in South Slavs.
    Adler G; Clark JS; Łoniewska B; Ciechanowicz A
    Croat Med J; 2011 Jun; 52(3):351-7. PubMed ID: 21674831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
    Preobrazhenskaya EV; Shleykina AU; Gorustovich OA; Martianov AS; Bizin IV; Anisimova EI; Sokolova TN; Chuinyshena SA; Kuligina ES; Togo AV; Belyaev AM; Ivantsov AO; Sokolenko AP; Imyanitov EN
    Int J Cancer; 2021 Jan; 148(1):203-210. PubMed ID: 32997802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Thousand Polish Genomes-A Database of Polish Variant Allele Frequencies.
    Kaja E; Lejman A; Sielski D; Sypniewski M; Gambin T; Dawidziuk M; Suchocki T; Golik P; Wojtaszewska M; Mroczek M; Stępień M; Szyda J; Lisiak-Teodorczyk K; Wolbach F; Kołodziejska D; Ferdyn K; Dąbrowski M; Woźna A; Żytkiewicz M; Bodora-Troińska A; Elikowski W; Król ZJ; Zaczyński A; Pawlak A; Gil R; Wierzba W; Dobosz P; Zawadzka K; Zawadzki P; Sztromwasser P
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
    Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
    Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
    ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
    BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
    Hamel N; Feng BJ; Foretova L; Stoppa-Lyonnet D; Narod SA; Imyanitov E; Sinilnikova O; Tihomirova L; Lubinski J; Gronwald J; Gorski B; Hansen Tv; Nielsen FC; Thomassen M; Yannoukakos D; Konstantopoulou I; Zajac V; Ciernikova S; Couch FJ; Greenwood CM; Goldgar DE; Foulkes WD
    Eur J Hum Genet; 2011 Mar; 19(3):300-6. PubMed ID: 21119707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.
    Cao WM; Gao Y; Yang HJ; Xie SN; Ding XW; Pan ZW; Ye WW; Wang XJ
    BMC Cancer; 2016 Feb; 16():64. PubMed ID: 26852015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update.
    Savanevich A; Ashuryk O; Cybulski C; Lubiński J; Gronwald J
    Hered Cancer Clin Pract; 2021 Jan; 19(1):13. PubMed ID: 33478551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome-based search for recurrent disease-causing alleles in Russian population.
    Yanus GA; Akhapkina TA; Whitehead AJ; Bizin IV; Iyevleva AG; Kuligina ES; Aleksakhina SN; Anisimova MO; Holmatov MM; Romanko AA; Zaitseva OA; Yatsuk OS; Zagorodnev KA; Matsneva MA; Koloskov AV; Togo AV; Suspitsin EN; Imyanitov EN
    Eur J Med Genet; 2019 Jul; 62(7):103656. PubMed ID: 31028847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HINT1 founder mutation causing axonal neuropathy with neuromyotonia in South America: A case report.
    de Aguiar Coelho Silva Madeiro B; Peeters K; Santos de Lima EL; Amor-Barris S; De Vriendt E; Jordanova A; Cartaxo Muniz MT; da Cunha Correia C
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1783. PubMed ID: 34562060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
    Meng H; Yao L; Yuan H; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Int J Cancer; 2020 Jun; 146(11):3044-3052. PubMed ID: 31957001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
    Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
    Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.
    Dodova RI; Mitkova AV; Dacheva DR; Hadjo LB; Vlahova AI; -Hadjieva MST; Valev SS; Caulevska MM; Popova SD; Popov IE; Dikov TI; Sedloev TA; Ionkov AS; Timcheva KV; Christova SL; Kremensky IM; Mitev VI; Kaneva RP
    BMC Cancer; 2015 Jul; 15():523. PubMed ID: 26183948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Characteristics of a Large Pediatric Cohort of Patients with Inborn Errors of Immunity: Single-Center Experience.
    Kuzmenko N; Alexenko M; Mukhina A; Rodina Y; Fadeeva M; Pershin D; Kieva A; Raykina E; Maschan M; Novichkova G; Shcherbina A
    J Clin Immunol; 2024 Jul; 44(7):165. PubMed ID: 39052144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
    Cherdyntseva NV; Pisareva LF; Ivanova AA; Panferova YV; Malinovskaya EA; Odintsova IN; Doroshenko AV; Gervas PA; Slonimskaya EM; Shivit-ool AA; Dvornichenko VV; Choinzonov YL
    Vestn Ross Akad Med Nauk; 2014; (11-12):72-9. PubMed ID: 25971130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.